Background: The role of sensitization to commercially available allergens of English
| INTRODUCTION
The nut of the English or common walnut tree (Juglans regia) is a frequently consumed tree nut. Ingestion of walnut is associated with potentially severe allergic symptoms in walnut allergic individuals. 1 Threshold analyses of walnut allergic adults indicated that walnut is a potent allergen, similar to hazelnut. 2 Walnut allergy appears to be one of the most reported tree nut allergies in the USA, where hazelnut allergy is most prevalent in Continental Europe. but at the time of writing, details were not available yet. Jug r 1 to 3 are currently commercially available for specific IgE (sIgE) testing, and we reported previously on their role in diagnosing walnut allergy. 1 While sensitization to Jug r 1 appears to be most prevalent in walnut allergic patients (61%), 11 cases could not be explained by sensitization to the currently available allergens, including 4 with moderate to severe walnut allergy. 1 At the same time, 11S globulins (like Jug r 4) are known to be major allergens in hazelnut and cashew allergy. 5, 6 Additionally, other unidentified allergens could play a role.
Therefore, we aimed to identify relevant walnut allergens, other than the previously investigated Jug r 1, 2 and 3 using immunoblot, immunoprecipitation and LC-MS and determine their diagnostic value in establishing walnut allergy in a cohort of 55 adult outpatients with a suspected walnut allergy.
| ME TH ODS

| Preparation of defatted walnut powder
The outer skin of the walnuts (Juglans regia) was removed using compressed air. The deskinned walnuts were frozen using liquid nitrogen and grinded using a mortar. The walnut particles were first freezedried to remove remaining water. After freeze-drying, the particles were defatted using a Soxhlet with petroleum ether. After the Soxhlet, the remaining petroleum ether was removed using a vacuum stove at 40°C. The defatted particles were further grinded using a Grindomix GM200 (Retsch, Aartselaar, Belgium) to obtain a fine powder.
| Extract preparation
Proteins were sequentially extracted from this defatted walnut powder (1 gr) using in succession 3 different buffers: 2 times 10 mL PBS (0.1 mol/L Sodium phosphate pH 7.2 + 0.85% NaCl), 2 times 10 mL of 8 mol/L Urea in PBS and 2 times 10 mL of 2% SDS + 1% DTT in PBS. After extracting the proteins for 60 minutes at a tube roller, the mixture was centrifuged for 10 minutes at 4500 g. The 2 supernatant fractions were pooled and immediately stored at −20°. In this way, 3
walnut extracts were obtained: PBS, Urea and SDS/DTT.
| Jug r 4 purification
Four grams of defatted walnut powder was extracted with 35 mL 0.1 mol/L sodium phosphate buffer + 0.85% NaCl pH 7.2. The extraction was performed in a 50-mL Greiner tube on a rotating disc. After 60-minute rotating, the suspension was centrifuged (30 minutes, 13300 g). The supernatant was discarded, and a second extraction with 35 mL 0.1 m sodium phosphate buffer + 0.85% NaCl pH 7.2 was performed for 15 minutes. The supernatant after the second centrifugation (30 minutes, 13300 g) was again discarded, and the pellet was extracted with 35 mL 50 mmol/L TRIS pH 8.1 + 2 mol/L NaCl. The pellet was dispersed in the buffer using a Potter-Elvehjem PTFE pestle and glass tube. 
| Patient selection
Previously, a prospective diagnostic study into walnut allergy was conducted. The study protocol was described elsewhere. 1 In short, adult outpatients with a suspected walnut allergy based on patient history were included, regardless of any previous skin prick test (SPT) or sIgE results. A double blind placebo controlled food challenge (DBPCFC) with walnut was performed to confirm or rule out walnut allergy. For the SDS-PAGE and the first immunoblotting experiments, 8 sera from allergic subjects were selected based on sensitization results for walnut extract and walnut components Jug r 1, 2 and 3 (Table S1 ). By selecting walnut allergic subjects with high, low and absence of sensitization to these 3 allergens, we aimed to identify all relevant allergenic proteins. For the assessment of the diagnostic value of identified allergens, sera from all 55 walnut challenged subjects were tested on immunoblot and line blot analysis.
Of these 55 subjects, 33 were walnut allergic and 22 tolerant (ie had a positive and negative challenge, respectively). PVDF blots were scanned for 600 seconds, and 50 scans were taken.
The scoring was performed with the 50-second scan. Nitrocellulose blots were scanned for 500 seconds, and 50 scans were taken. The scoring was performed with the 52-second scan. Half of the resulting peptide mixture was purified by StageTip
| Identification of IgE binding proteins
SCX (EmporeTM Cation 47 mm Extraction Disks), in accordance with
Rappsilber et al 9 The eluate from the SCX cleanup was evaporated to dryness and resuspended in 30 μL of mobile phase A (2% Acetonitrile/0.1% formic acid (v/v)).
| NanoLC-MS/MS and database search
NanoLC-MS/MS analysis was performed on an Easy LC 1000 nanoscale liquid chromatography (nanoLC) system (Thermo Fisher Scientific, Odense, Denmark) coupled to a Q-Exactive mass spectrometer (Thermo Scientific, Bremen, Germany).
The analytical column was a 10-cm pulled fused silica capillary high confidence peptides (confidence >99%) were filtered out, using
Percolator, integrated in Proteome Discoverer. Protein hits based on 2 successful peptide identifications were considered valid.
| EUROLINE
In the 55 walnut challenged subjects, sensitization to recombinant Jug r 4.0101 was assessed using a line blot (EUROLINE, EUROIM-MUN, Lübeck, Germany) according to manufacturer's instructions.
EUROIMMUN kindly provided the line blots and reagents. Briefly, the test strips were incubated at room temperature on a rocking shaker overnight patient sera diluted 1:11 in working strength universal buffer (WSUB). Bound antibodies were visualized with an enzyme-labelled anti-human IgE antibody in combination with the substrate nitro-blue tetrazolium/5-bromo-4-chloro-3′-indolyphosphate.
The reaction was evaluated using the software "EUROLineScan". The intensity of the bands was reported as an intensity level and a class, corresponding to the Enzyme-Allergo-Sorbent Test classification (class 0-6). 10 A class of 1 or higher, corresponding to intensity level of 3 or higher, was considered positive.
| Data analysis and statistics
The immunoblot results were independently scored by 3 researchers, blinded to challenge and sensitization results. Discrepancies in scores were discussed in a panel meeting until agreement was reached. To assess the performance of the diagnostic tests, sensitivity, specificity, positive and negative predictive value were calculated. The diagnostic value was determined by calculating the area under the curve (AUC) of the receiver operating characteristic (ROC) curve. All analyses were performed using SPSS Statistics 21 (IBM Corporation, Armonk, NY, USA).
| RESULTS
| IgE binding proteins identified as Jug r 1, Jug r 2 and Jug r 4
As described earlier, sera from 8 allergic subjects were selected, based on varying sensitization profiles of Jug r 1, Jug r 2 and Jug r 3 (Table S1 ), to explore walnut protein recognition by IgE. Figure 1 shows two representative immunoblots using the 3 reduced walnut (Table S3 ).
| Jug r 4 detected in subgroup of walnut challenged subjects
As sensitization to Jug r 4 had not yet been investigated in our previously characterized cohort of 55 walnut challenged subjects, 1 Figure S1 and Table S4 ). All 5 subjects positive on immunoblot were positive on EUROLINE as well. Of the 10 Jug r 4 sensitized subjects on EUROLINE, all but one had a positive food challenge. This results in a sensitivity and specificity of 27% and 95%, respectively, and a positive and negative predictive value of 90% and 47%, respectively. ROC curve analysis returned an AUC value for rJug r 4 of 0.61.
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| Jug r 4 not detected in walnut extract on ImmunoCAP
No Jug r 4 (and Jug r 3) could be detected in the ImmunoCAP walnut extract, using LC-MS analyses (Table S5 ). Other allergens including Jug r 1 and jug r 2 could be distinctly identified.
| Jug r 4 co-sensitizes with Jug r 1 and other
11S globulins
Co-sensitization to other walnut components was present in all subjects sensitized to rJug r 4 (Table 1) To assess potential cross-reactivity, sensitization to other 11S globulins on ImmunoCAP ISAC was assessed in the 10 subjects sensitized to rJug r 4 ( Table 2 ). Co-sensitization to hazelnut Cor a 9 was most frequent (6 of 10), followed by cashew Ana o 2, soy Gly m 6
and peanut Ara h 3.
| DISCUSSION
In this study, we screened walnut allergic adults, using both Table S2 T A B L E 1 Sensitisation profile of 10 subjects with specific IgE to either nJug r 4 on immunoblot or rJug r 4 on EUROLINE OAS, oral allergy symptoms; U, urticaria; AE, angioedema; R, rhinitis; C, conjunctivitis; Dy, dyspnoea; A, abdominal pain/nausea; Dz, dizziness; P, pruritus; V, vomiting; CAP, ImmunoCAP; ISAC, ImmunoCAP ISAC. walnut, has been demonstrated before. 13 Zhang et al 12 showed, using immunoblotting experiments, that 9 of 27 (33%) sera of walnut allergic patients from the United States were positive for nJug n 4, which is similar to the 27% rJug r 4 we found in our cohort. (Table 1) with a negative challenge, notably also with concomitant (irrelevant) sensitization to Jug r 1. In our 11 walnut allergic adults not sensitized to any of the available component, as discussed in the introduction, no sensitization to Jug r 4 was found. In these subjects, other walnut allergens are expected to play a role.
Subject
In the total cohort, co-sensitization to multiple walnut allergens was very common. Interestingly, co-sensitization to 2 or more walnut components (Jug r 1, 2, 3 and/or 4) was strongly associated with a positive challenge (14 of 15; 93%). Additionally, all 4 subjects co-sensitized to 3 components (Jug r 1, 2 and 4) had a positive challenge.
Additionally, there appeared to be a trend of more severe symptoms (Mueller 2-3 vs 0-1) in subjects co-sensitized to more than one walnut component, but this was not statistically significant (data not shown).
We also found that the walnut extract on ImmunoCAP appears to contain Jug r 1 and Jug r 2, but lacks Jug r 4 (and Jug r 3). All our Jug r 4 sensitized subjects had sIgE against the walnut extract on
ImmunoCAP, which can be explained by co-sensitization to other walnut allergens. Subject 40, however, sensitized to Jug r 3 and 4, also was sensitized to the walnut extract (Table 1 ). It therefore remains unknown which allergen in the walnut extract was recognized by this subject. | 1211
Overall, we found a decent concordance between nJug r 4 on the immunoblots and the EUROLINE blots with rJug r 4. Jug n 4, respectively, alone or to both subunits, using sera from walnut allergic subjects.
11,12
Jug r 4 has sequence identity with 11S globulins from other tree nuts, such as hazelnut Cor a 9 (63%) and cashew Ana o 2 (53%).
11
Previous epitope mapping and 3D structural analysis of Jug r 4 also revealed similar IgE binding sites on 11S globulins from cashew, hazelnut, peanut and soya bean, 15, 16 potentially leading to cross-reactivity. Also for sesame 11S globulin Ses i 6, in vitro crossreactivity with Jug r 4 was previously established by inhibition immunoblotting using sera of 37 patients with a history of severe reactions to peanut, walnut and/or sesame. 17 In our study, co-sensitization to one or more 11S globulins from these 4 foods on Immuno-CAP ISAC was observed in 7 subjects, further supporting the potential role of cross-reactivity between 11S albumins from these foods. Overall, co-sensitization to hazelnut Cor a 9 occurred most frequently. Previously, we established cross-reactivity between Cor a 9 and peanut Ara h 3 using ImmunoCAP inhibition, although only in few cases. 18 Notably, the 2 subjects with the strongest sensitization (ie highest intensity values) to Jug r 4 on EUROLINE (subject 8 and 25) both demonstrated co-sensitization to all 4 other 11S globulins on ISAC. In the EuroPrevall study, a strong correlation was found between Cor a 9 and walnut extract in subjects from Prague as well as from our centre in Utrecht, but not in other centres. 19 This can be explained by the apparent absence of Jug r 4 from the Immuno-CAP extract as established in this study. The lack of Jug r 4 in the ImmunoCAP extract could be the result of poor solubility of Jug r 4.
Jug r 4 requires a high salt buffer (at least 2 mol/L NaCl) for complete solubility.
In conclusion, we established that walnut 11S globulin Jug r 4 is a relevant allergen in walnut allergy and is not present in the commercially available ImmunoCAP extract. Specific IgE against Jug r 4 occurred in a subset of subjects, mostly with concomitant sensitization to other walnut components, and has a high positive predictive value of 90% for walnut allergy. In Jug r 4 sensitized subjects, cosensitization to other 11S globulins is common, potentially due to cross-reactivity.
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